Moreover, BMP2 promotes bone metastasis of breast and prostate cancer via the AKT pathway, but BMP9 was shown to inhibit the AKT signaling in breast cancer and, thus, suppresses the formation of bone metastases. The gene discussed is BMP2; the disease is breast carcinoma.